Atlassian uses cookies to improve your browsing experience, perform analytics and research, and conduct advertising. Accept all cookies to indicate that you agree to our use of cookies on your device. Atlassian cookies and tracking notice, (opens new window)
Welcome to the PHUSE Advance Hub

WORKING GROUPS
Results will update as you type.
  • Working Groups
  • Hot Topics
  • Useful Information
  • Deliverables
  • Working Groups Events
  • Working Groups Report – Q3 2025
  • Working Groups Archive
    • Data Transparency Archive
      • Clinical Trials Data Transparency Toolkit
      • Data De-identification Toolkit
      • Good Transparency Practices
      • Rare Disease/Small Population Data Sharing
      • PHUSE De-identification Standards
      • Policy 0070 Interpretations
      • Stakeholders’ Deliverables Review
      • Synthetic Data
      • Terminology Harmonisation in Data Sharing & Disclosure Deliverables
      • Write Standard Programs Your People Will Use And Love!!
    • Data Visualisation & Open Source Technology Archive
    • Emerging Trends & Technologies Archive
    • Nonclinical Topics Archive
    • Optimizing the Use of Data Standards Archive
    • Risk Based Quality Management Archive
    • Real World Evidence Archive
    • Therapeutic Areas
    • Good Programming Practice Project Team
    • Working Group Report Archive
    • Safety Analytics Archive
  • Working Groups Events Archive

    You‘re viewing this with anonymous access, so some content might be blocked.
    /
    Rare Disease/Small Population Data Sharing

      Rare Disease/Small Population Data Sharing

      Sept 30, 2025

      Project Scope

      The goal of this project is to develop a resource for individuals who are anonymising or supporting/facilitating the sharing of rare disease or low population data. The aim is to produce a white paper which provides guidance, recommendations and methodologies for the handling of data from rare diseases/small populations. Although this project may not result in a “perfect” document, the aim is to have something that will be a foundation for future work.

      Part of the challenge for this project is determining the scope. Since there isn’t currently a document like the one being proposed, we are aiming to potentially cover a number of topics:

      • Defining what is meant by rare disease and low population datasets
      • The risks associated with sharing such data, and how the context of data use impacts risk
      • Anonymisation and data utility considerations given the size of such datasets
      • The concept of data sensitivity as a component requiring specific consideration for these datasets
      • How the sharing of genetic information impacts the risk, given that many rare diseases often have a genetic component
      • Considerations for presenting summary data in publications based on rare disease or low population datasets
      • Patient perspectives on sharing
      • Gap analysis of the current literature

      One of the key components is whether we will be splitting the document into two different sub-documents, one focussing on controlled access datasets and the other on publicly accessible ones. We are currently working on the assumption that this will be a single document, and will re-evaluate as the project evolves. A secondary goal will be supporting facilitation of other organisations developing their own guidance documentation on rare disease/small population data collection. 

      Problem Statement

      Sharing of rare disease and low population datasets poses unique challenges. There is not currently a consolidated source of information to document and further the understanding of these challenges in order to support the sharing of this specialised data. This Working Group is aiming to develop documentation that will support those working in these areas of clinical/medical research. This will allow those researchers and others interested to understand the unique risks associated with this data and to develop standardised methods to share this data in a manner which protects privacy, while at the same time affording data utility.

      Problem Impact
      This project will impact the industry by providing a comprehensive, cross-regulatory document that will act as a go-to resource for individuals working to anonymise and share rare disease or low population datasets. By providing recommendations on areas that are currently lacking in guidance, this project will be able to help lead rare disease/small population research to the level that other areas of medicine have already attained. The hope is that this document will not only make research more efficient but also give patients and their families a sense of security by understanding how their data is being handled.
      Project LeadsEmail 
      Karolina Stępniak, AstraZenecakarolina.stepniak@astrazeneca.com
      Helen Spotswood, Roche helen.spotswood@roche.com
      Lucy Marks, PHUSE Senior Project Coordinatorlucy@phuse.global

      CURRENT STATUS (Updated Quarterly) 

      • White paper published.
      • Project now closed.
      Objectives & DeliverablesTimelines
      White PaperQ2 2025
      , multiple selections available, Use left or right arrow keys to navigate selected items
      unrestored-unknown-attachment
      {"serverDuration": 41, "requestCorrelationId": "a6d39f9ac66d4b938ee6389a6acff91b"}